HC Wainwright & Co. Reiterates Buy on SpyGlass Pharma, Maintains $37 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.8%

Neg 0% Neu 87.8% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates SpyGlass Pharma (NASDAQ:SGP) with a Buy and maintains $37 price target.

Comments

No comments yet. Be the first!